Golidocitinib, a selective JAK1 kinase inhibitor, in treatment of late thrombocytopenia after CAR-T cell therapy: Case report
Year: 2025
Type: conference-abstract
Source: Blood
Authors: Qichun Cai, Jianing Li, Jiasheng Li, Ge Zhang, Feifei Ma, Kailin Ding, Huajuan Ma, Gao Yan, Haijun Wen
Institutions: Sun Yat-sen University, Sun Yat-sen University Cancer Center
Language: English
Topic: CAR-T cell therapy research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4417010100
Cites:
Cited by:
Related to: